Feb 8, 2019
This week's View offers key points to remember from a review on heart failure with preserved ejection fraction and diabetes and addresses the comparative durabilities of transcatheter aortic valve replacement (TAVR) and surgical bioprosthetic aortic valve replacement and the incidence of structural valve degeneration 5-10 years after TAVR.